Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The first half of 2025 has confirmed a seismic shift in the pharmaceutical landscape: GLP-1 receptor agonists a class of new drug therapies for diabetes and obesity now dominate global sales charts
By inhibiting the NP (natriuretic peptide) system, sacubitril/valsartan increases natriuretic peptides (NPs) levels that, in turn, lead to vasodilation, natriuresis and RAAS inhibition through intracellular cyclic guanosine monophosphate (cGMP)-dependent pathways
There's not much prep involved
This compound is part of our Peptides category, which includes a range of laboratory-grade peptide compounds studied in controlled environments
Online claims of a '33-hour half-life' confuse those two things
US$ 23.96
US$ 26.91
US$ 27.66
US$ 28.67
US$ 25.95
US$ 21.22
.webp)
US$ 21.96
US$ 27.64
US$ 28.23
US$ 22.79
